views
Europe Point of Care Diagnostics Market
Market Introduction
Europe is the second-largest market for point of care diagnostics, and the UK, Germany, France, Italy, Spain, and rest of Europe are the major contributors to this market in this region. The growth of the market in Europe is characterized by the rise in the demand for advanced diagnostic solutions, rising prevalence of infectious and chronic conditions, and increase in the investment for research and development. Also, the presence of well-established manufacturing infrastructure for advanced diagnosis products is likely to propel the growth of the Europe point of care diagnostics market during the forecast period. Germany led the market. The government of Germany is putting efforts to improve the medical conditions for the people suffering from various health conditions. For instance, in November 2017, Lilly Germany developed the Diabetes Work initiative. The initiative was launched to spread the awareness regarding diabetes, which is expected to offer a lucrative opportunity for adoption of diagnostic kits. Further, in September 2018, the Germany government gave permission to market and sale OTC HIV home testing kits. Such constructive developments are projected to drive the growth of Europe point of care diagnostics market during the forecast period.
📚Download Full PDF Sample Copy of Market Report @
https://www.businessmarketinsights.com/sample/TIPRE00023727
In case of COVID-19, Europe is highly affected specially France. The European economy is severely affected due to the exponential growth of COVID-19 cases in the region. Spain, Italy, Germany, France, and the UK are among the most affected European countries and number of deaths are also high. The current coronavirus (COVID-19) outbreak has been declared by WHO as a Public Health Emergency of International Concern, according to the International Health Regulation. Increasing number of coronavirus infections and demand for advanced diagnostic solutions is offering a favorable opportunity for adoption of point of care diagnostic kits in the region. Moreover, rising investments and business activities by industry players is also boosting the market even in pandemic situations. In 2020, European Medicines Agency (EMA) approved about 97 medicines for marketing authorization of which, 39 are novel drugs. Similarly, in October 2020, Eurofins introduces COVID-19 PCR tests with at-home self-sampling options in Europe region. Moreover, in October 2020, Siemens Healthineers launched rapid antigen test for diagnosis of COVID-19 in European countries. The CLINITEST rapid COVID-19 test is point of care cassette test that offers test result in 15 minutes. In addition, in April 2021, QIAGEN announced launch of Prep&Amp technology in order accelerate the COVID-19 diagnosis in Europe. The kit has received CE approval for marketing and distribution in Europe, also, the company has submitted its product for EUA (Emergency Use Application) in US. Such activities are likely to have constructive impact on market growth.
Strategic Insights: Europe Point of Care Diagnostics Market
Strategic insights into the Europe Point of Care (POC) Diagnostics market offer a data-driven examination of the industry, highlighting emerging trends, key market players, and regional distinctions. These insights provide actionable guidance to help stakeholders—whether investors, manufacturers, or healthcare providers—identify untapped opportunities and craft distinctive value propositions. By leveraging advanced analytics, market participants can stay ahead of industry shifts and adapt their strategies accordingly. A forward-looking approach is essential, enabling businesses to anticipate changes, minimize risks, and capitalize on growth potential in this evolving market. Ultimately, these strategic insights support informed decision-making that drives profitability, enhances competitiveness, and ensures sustainable success across the European POC diagnostics landscape.
Europe Point of Care Diagnostics Regional Insights
The geographic scope of the Europe Point of Care Diagnostics refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
Key Market Segments
In 2020, the glucose monitoring products segment held the largest share of the Europe point of care diagnostics market by product type. Based on prescription mode, prescription-based testing dominated the market. In terms of end users, professional diagnostic centers accounted for the largest market share.
Major Sources and Companies Referenced
This report draws on a variety of primary and secondary sources, including company websites, annual and financial reports, national government publications, and statistical databases. Key players profiled in the report include:
- Abbott
- BD
- bioMérieux SA
- Bio-Rad Laboratories Inc.
- Danaher Corporation
- F. Hoffmann-La Roche Ltd.
- Johnson & Johnson Services, Inc.
- Nova Biomedical
- Polymer Technology Systems, Inc. (PTS)
- Siemens AG
Reasons to Purchase This Report
- Gain a comprehensive understanding of the Europe point of care diagnostics market landscape and identify the most lucrative market segments.
- Stay competitive by tracking key market trends and developments in a dynamic industry environment.
- Strategically plan mergers, acquisitions, and partnerships by targeting segments with the highest growth potential.
- Make informed business decisions backed by detailed analysis of segment performance across the European market.
- Access revenue forecasts for various market segments from 2021 to 2028 to guide long-term strategy.
About Us:
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Défense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications
Author's Bio
Akshay
Senior Market Research Expert at Business Market Insights
Comments
0 comment